ATE208758T1 - Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten - Google Patents

Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten

Info

Publication number: ATE208758T1
Authority: AT; Austria
Prior art keywords: pct; solid compositions; magnesium tartrate; carnitine magnesium; oral administration
Prior art date: 1997-04-07

Application number

AT98912694T

Other languages

English (en)

Inventor

Maria Ornella Tinti

Nazareno Scafetta

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-07

Filing date

1998-03-19

Publication date

2001-11-15

1998-03-19 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2001-11-15 Application granted granted Critical

2001-11-15 Publication of ATE208758T1 publication Critical patent/ATE208758T1/de

Links

229940095060 magnesium tartrate Drugs 0.000 title abstract 2
MUZDLCBWNVUYIR-ZVGUSBNCSA-L magnesium;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Mg+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O MUZDLCBWNVUYIR-ZVGUSBNCSA-L 0.000 title abstract 2
239000008247 solid mixture Substances 0.000 title abstract 2
235000015872 dietary supplement Nutrition 0.000 abstract 2
230000000378 dietary effect Effects 0.000 abstract 1
ZQJMKXKBQGAVCW-QYCVXMPOSA-L magnesium;2,3-dihydroxybutanedioate;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound [Mg+2].[O-]C(=O)C(O)C(O)C([O-])=O.C[N+](C)(C)C[C@H](O)CC([O-])=O ZQJMKXKBQGAVCW-QYCVXMPOSA-L 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000013589 supplement Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Animal Husbandry (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT98912694T 1997-04-07 1998-03-19 Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten ATE208758T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT97RM000195A IT1291133B1 (it)	1997-04-07	1997-04-07	Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato
PCT/IT1998/000059 WO1998045250A1 (en)	1997-04-07	1998-03-19	Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate

Publications (1)

Publication Number	Publication Date
ATE208758T1 true ATE208758T1 (de)	2001-11-15

Family

ID=11404944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98912694T ATE208758T1 (de)	1997-04-07	1998-03-19	Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten

Country Status (16)

Country	Link
US (1)	US6130249A (de)
EP (1)	EP0971879B1 (de)
JP (1)	JP2001524078A (de)
KR (1)	KR100556237B1 (de)
CN (1)	CN1177808C (de)
AT (1)	ATE208758T1 (de)
AU (1)	AU731316B2 (de)
BR (1)	BR9808489A (de)
CA (1)	CA2285550C (de)
DE (1)	DE69802512T2 (de)
DK (1)	DK0971879T3 (de)
ES (1)	ES2166596T3 (de)
IT (1)	IT1291133B1 (de)
NZ (1)	NZ500538A (de)
PT (1)	PT971879E (de)
WO (1)	WO1998045250A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1305308B1 (it) *	1999-03-26	2001-05-04	Biosint S P A	Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
JP4539096B2 (ja) *	2004-01-16	2010-09-08	日油株式会社	油性成分被覆ｌ−カルニチン塩粉末およびその用途
US20050232911A1 (en) *	2004-04-19	2005-10-20	Schreiber Brian D	Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101209975B (zh)	2006-12-29	2010-12-01	沈阳科硕营养科技有限公司	左旋肉碱富马酸钙及其制备方法与用途
US8996409B2 (en)	2007-06-06	2015-03-31	Sony Computer Entertainment Inc.	Management of online trading services using mediated communications
EP2425834A1 (de) *	2010-09-06	2012-03-07	Lonza Ltd.	Verfahren zur Herstellung von L-Carnitin-Tartrat
US9105178B2 (en)	2012-12-03	2015-08-11	Sony Computer Entertainment Inc.	Remote dynamic configuration of telemetry reporting through regular expressions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1153640A (en) *	1967-04-10	1969-05-29	Soc D Etudes Prod Chimique	A Carnitin Salt
FR2529545B1 (fr) *	1982-07-02	1985-05-31	Sanofi Sa	Nouveaux sels de carnitine ainsi que leur procede de preparation
EP0150688B1 (de) *	1983-12-28	1987-04-22	Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.	Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben
CA2018137C (en) *	1989-06-14	2000-01-11	Thomas Scholl	L-carnitine magnesium citrate
US5073376A (en) *	1989-12-22	1991-12-17	Lonza Ltd.	Preparations containing l-carnitine
IT1261688B (it) *	1993-05-28	1996-05-29	Avantgarde Spa	Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

1997
- 1997-04-07 IT IT97RM000195A patent/IT1291133B1/it active IP Right Grant
1998
- 1998-03-19 CN CNB988038455A patent/CN1177808C/zh not_active Expired - Fee Related
- 1998-03-19 BR BR9808489-5A patent/BR9808489A/pt not_active Application Discontinuation
- 1998-03-19 US US09/381,831 patent/US6130249A/en not_active Expired - Fee Related
- 1998-03-19 AU AU67454/98A patent/AU731316B2/en not_active Ceased
- 1998-03-19 ES ES98912694T patent/ES2166596T3/es not_active Expired - Lifetime
- 1998-03-19 PT PT98912694T patent/PT971879E/pt unknown
- 1998-03-19 DK DK98912694T patent/DK0971879T3/da not_active Application Discontinuation
- 1998-03-19 AT AT98912694T patent/ATE208758T1/de not_active IP Right Cessation
- 1998-03-19 EP EP98912694A patent/EP0971879B1/de not_active Expired - Lifetime
- 1998-03-19 JP JP54256598A patent/JP2001524078A/ja not_active Ceased
- 1998-03-19 NZ NZ500538A patent/NZ500538A/xx unknown
- 1998-03-19 CA CA002285550A patent/CA2285550C/en not_active Expired - Fee Related
- 1998-03-19 KR KR1019997008942A patent/KR100556237B1/ko not_active Expired - Fee Related
- 1998-03-19 DE DE69802512T patent/DE69802512T2/de not_active Expired - Lifetime
- 1998-03-19 WO PCT/IT1998/000059 patent/WO1998045250A1/en not_active Ceased

Also Published As

Publication number	Publication date
DE69802512T2 (de)	2002-08-01
CN1251572A (zh)	2000-04-26
CA2285550C (en)	2008-07-08
AU6745498A (en)	1998-10-30
HK1025561A1 (en)	2000-11-17
WO1998045250A1 (en)	1998-10-15
CN1177808C (zh)	2004-12-01
KR100556237B1 (ko)	2006-03-03
EP0971879B1 (de)	2001-11-14
CA2285550A1 (en)	1998-10-15
PT971879E (pt)	2002-05-31
BR9808489A (pt)	2000-05-23
IT1291133B1 (it)	1998-12-29
DE69802512D1 (de)	2001-12-20
EP0971879A1 (de)	2000-01-19
JP2001524078A (ja)	2001-11-27
ITRM970195A1 (it)	1998-10-07
AU731316B2 (en)	2001-03-29
NZ500538A (en)	2001-03-30
US6130249A (en)	2000-10-10
KR20010005866A (ko)	2001-01-15
ES2166596T3 (es)	2002-04-16
DK0971879T3 (da)	2002-03-25

Legal Events

Date	Code	Title	Description
2002-05-15	UEP	Publication of translation of european patent specification
2011-12-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69806590D1 (de)	2002-08-22	Feste zusammensetzungen für orale verabreichung die l-carnitine oder alkanoyl-l-carnitin-magnesium-fumarat enthalten
DE69810601D1 (de)	2003-02-13	Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung
DE69802512D1 (de)	2001-12-20	Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten
DE69802518D1 (de)	2001-12-20	Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten
DE69802789D1 (de)	2002-01-17	Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten
CA1330649C (fr)	1994-07-12	Compositions destinees a augmenter la productivite de truies reproductrices et usage desdites compositions
DE50011533D1 (de)	2005-12-15	Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arznelmittel in Form von Tabletten
CA2124925A1 (en)	1993-06-10	Preparation of dietary fatty acid salt products